Nicotinamide Riboside (NR) Market Report 2026

The nicotinamide riboside (NR) market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing adoption of nutraceutical supplements, growing consumer interest in anti-aging solutions, rising awareness of metabolic and mitochondrial health, expansion of online supplement sales channels, increasing pharmaceutical research on NAD⁺ boosting compounds.

The nicotinamide riboside (NR) market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growing demand for longevity and cellular rejuvenation products, increasing interest in personalized wellness and precision nutrition, rising incorporation of NR into multi-ingredient formulations, expansion of distribution across pharmacies and specialty health stores, growing investments from nutraceutical and pharmaceutical manufacturers. Major trends in the forecast period include technology advancements in nr formulation stability and bioavailability, innovations in delivery systems such as sustained release capsules, developments in functional food and beverage fortification with nr, research and development in nad⁺ pathway therapeutics, advancements in DNA-based and biomarker-driven supplement customization.

The increasing health consciousness among consumers is expected to drive the growth of the nicotinamide riboside (NR) market in the coming years. Health consciousness refers to individuals’ awareness and proactive approach toward maintaining good health through lifestyle and dietary choices. This trend is rising due to greater awareness of diet-related diseases, encouraging more people to select nutritious foods and reduce sugar intake. Health consciousness boosts NR adoption by increasing demand for supplements that support cellular energy, healthy aging, and metabolic function. It promotes market growth by fostering proactive wellness behaviors and interest in scientifically validated nutritional ingredients. For example, in June 2024, the International Food Information Council, a US-based nonprofit organization, reported that the proportion of Americans focusing on consuming more protein increased from 59% in 2022 to 67% in 2023 and 71% in 2024. Consequently, the growing health consciousness among consumers is fueling the growth of the NR market.

Leading companies in the nicotinamide riboside (NR) market are focusing on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD⁺) skincare supplements, to promote anti-aging and enhance skin health. NAD⁺ skincare supplements are dietary or topical products designed to boost NAD⁺ levels in skin cells, supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For example, in April 2024, ChromaDex Corporation, a US-based NAD⁺ bioscience company, launched Tru Niagen at The Vitamin Shoppe. This healthy-aging NAD⁺ supplement is formulated to safely and effectively elevate NAD⁺ levels in adults, supporting cellular health, energy production, and overall well-being. The nationwide rollout makes the product widely accessible to consumers seeking science-based support for age-related declines in metabolic function.

In October 2023, L Catterton Management Company LLC, a US-based consumer-focused investment firm, acquired Thorne HealthTech Inc. for an undisclosed sum. This acquisition allowed L Catterton to expand its presence in the personalized wellness and longevity-focused nutrition markets by leveraging Thorne’s established product portfolio, research and development capabilities, and direct-to-consumer reach. Thorne HealthTech Inc. is a US-based nutritional supplement company specializing in nicotinamide riboside (NR) products that support cellular health and healthy aging.

Major companies operating in the nicotinamide riboside (nr) market are Zhejiang NHU Company Ltd., Designs for Health Inc., Niagen Bioscience Inc., Cayman Chemical Company, Jinan Qinmu Fine Chemical Co. Ltd, Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering (Shenzhen) Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology (Shanghai) Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou Myland Nutraceuticals Inc., Chromadex Inc.

North America was the largest region in the nicotinamide riboside market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide riboside (nr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nicotinamide riboside (nr) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the nicotinamide riboside market by increasing costs of imported active ingredients, encapsulation materials, analytical testing services, and nutraceutical manufacturing equipment. north america and europe are most affected due to reliance on cross-border sourcing of high-purity nr compounds, while asia-pacific faces cost pressure on contract manufacturing and exports. these tariffs are elevating retail prices and impacting margins for supplement brands. at the same time, they are encouraging domestic synthesis of nr, regional supply chain development, and investment in localized nutraceutical manufacturing infrastructure.

Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD⁺), an essential coenzyme in cellular energy metabolism. Its main function is to increase NAD⁺ levels in cells, supporting mitochondrial function, energy production, and healthy aging. NR is commonly used as a dietary supplement to improve metabolic health and promote overall cellular vitality.

The primary product types of nicotinamide riboside (NR) products include capsules, tablets, powders, and other product types. Capsules refer to orally administered nicotinamide riboside formulations designed to support cellular energy metabolism, healthy aging, and overall wellness. The distribution channels include online retail, health and wellness stores, pharmacies and drugstores, supermarkets and hypermarkets, and specialty stores. The applications span dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition, and the key users are across dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition.

The nicotinamide riboside (NR) market consists of sales of capsules, tablets, and powder supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.